Molecular and flow cytometric analysis have improved the diagnosis of clonal lymphoid proliferations in the lung, though further studies are needed to define prognostic features and targeted therapies.
No takes yet. Share an insight, caveat, or question.
Enhances diagnostic precision for pulmonary lymphoid proliferations; leaves open needs for prognostic and therapeutic studies.
William et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: